Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
13,390
+480 (3.72%)
At close: Jun 9, 2026
Sam-A Pharm. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8,887 | 12,940 | 22,080 | 21,374 | 11,912 | 3,392 |
Depreciation & Amortization | 4,187 | 4,808 | 4,266 | 3,895 | 3,187 | 3,699 |
Loss (Gain) From Sale of Assets | -146.71 | - | - | - | - | - |
Loss (Gain) From Sale of Investments | -1,009 | -898.58 | -404.35 | -907.91 | 1,335 | 308.52 |
Loss (Gain) on Equity Investments | 1,076 | 863.72 | 932.85 | 915.83 | 1,290 | 2,464 |
Provision & Write-off of Bad Debts | -135.69 | -150.79 | 26.23 | -40.36 | - | 16.74 |
Other Operating Activities | -3,542 | -3,771 | 7.04 | -1,149 | 2,284 | 1,485 |
Change in Accounts Receivable | 3,011 | -256.7 | 3,510 | -1,090 | -3,427 | -2,638 |
Change in Inventory | 876.35 | -2,357 | -1,447 | -885.95 | -2,975 | 2,666 |
Change in Accounts Payable | -3,445 | -1,652 | 827.33 | -2,038 | 3,268 | 1,210 |
Change in Other Net Operating Assets | -36.69 | 1,198 | -4,551 | 686.51 | 2,730 | 339.61 |
Operating Cash Flow | 9,722 | 10,723 | 25,247 | 20,760 | 19,604 | 12,943 |
Operating Cash Flow Growth | -53.24% | -57.53% | 21.62% | 5.90% | 51.47% | 37.57% |
Capital Expenditures | -1,694 | -1,370 | -6,512 | -3,820 | -239.25 | -275.44 |
Sale of Property, Plant & Equipment | 29.4 | 29.4 | - | - | 140.21 | 4.55 |
Sale (Purchase) of Intangibles | -181.26 | -358.53 | 109.09 | 263.64 | 1,100 | 1,050 |
Investment in Securities | 1,427 | -1,162 | -15,160 | -17,251 | -24,423 | -34,375 |
Other Investing Activities | 247.67 | 302.41 | 151.75 | -0 | 10,390 | 13,800 |
Investing Cash Flow | -171.32 | -2,559 | -21,411 | -20,807 | -13,032 | -19,796 |
Long-Term Debt Issued | - | - | 5,000 | 5,000 | - | - |
Total Debt Issued | - | - | 5,000 | 5,000 | - | - |
Long-Term Debt Repaid | - | -6,246 | -3,945 | -2,670 | -3,855 | -1,839 |
Net Debt Issued (Repaid) | -6,261 | -6,246 | 1,055 | 2,330 | -3,855 | -1,839 |
Dividends Paid | -4,883 | -4,883 | -4,578 | -2,441 | -1,526 | -1,831 |
Financing Cash Flow | -11,143 | -11,129 | -3,522 | -111.77 | -5,381 | -3,670 |
Foreign Exchange Rate Adjustments | 5.59 | -6.08 | 217.64 | 2.45 | - | 111.9 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | -0 | 0 |
Net Cash Flow | -1,587 | -2,970 | 531.73 | -156.46 | 1,191 | -10,411 |
Free Cash Flow | 8,029 | 9,353 | 18,735 | 16,940 | 19,365 | 12,667 |
Free Cash Flow Growth | -49.89% | -50.08% | 10.60% | -12.52% | 52.88% | 45.13% |
Free Cash Flow Margin | 11.32% | 12.02% | 19.60% | 17.43% | 23.70% | 23.17% |
Free Cash Flow Per Share | 1315.31 | 1532.45 | 3069.99 | 2775.59 | 3172.89 | 2075.46 |
Cash Interest Paid | 413.41 | 425.21 | 519.8 | 214.56 | 2.85 | 29.07 |
Cash Income Tax Paid | 5,125 | 6,596 | 7,481 | 7,186 | 4,228 | 802.31 |
Levered Free Cash Flow | 2,519 | 3,539 | 11,778 | 9,634 | 17,658 | 11,749 |
Unlevered Free Cash Flow | 2,795 | 3,815 | 12,115 | 9,771 | 17,697 | 11,827 |
Change in Working Capital | 405.18 | -3,068 | -1,660 | -3,327 | -403.53 | 1,577 |